Академический Документы
Профессиональный Документы
Культура Документы
DR. FAJARDO
Etiology
Infections caused by anaerobes mostly
polymicrobial
Major anaerobic gram positive cocci that produce
disease is Peptostreptococcus sp.
Clostridia spore-forming gram-positive rods most
common isolated organism found in wounds,
abscesses, abdominal infections, blood
Propionibacterium acnes gram positive rod, non
spore forming; involve in formation of acne
Principal anaerobic gram negative bacilli found in
human infections
o B. fragilis group - MC
o Fusobacterium
o Prevotella
o Porphyromonas sp.
Pathogenesis
Disrupted anatomic barrier leads to entry of local
flora in a previously sterile site
Factors that allow organism to penetrate mucosal
barrier are:
o Tissue ischemia
o Trauma
o Surgery
o Perforated viscus (ie. Rupture appendixcolonic contents which is unsterile goes into
peritoneum that is sterile ->peritonitis)
o Shock
o Aspiration oral flora will go to the lungs
creating anaerobic infection
o *all of which provide an environment
conducive for proliferation of anaerobes
Cervicofacial actinomycosis
o Caused by a branching, gram positive, nonspore-forming, strict/facultative anaerobe
that is a part of the normal oral flora
o Chronic disease - characterized by
abscesses, draining sinus tracts, fistula,
bone destruction, and fibrosis
o It can easily be mistaken for malignancy or
granulomatous disease
o *DDx: TB adenitis or lymphoma d/t the
draining sinus (bone involvement =
Actinomycosis)
1. Pharyngitis
2. A tender/swollen neck (d/t
involvement of internal jugular
vein)
3. Noncavitating pulmonary
infiltrates (in Chest X-ray)
CNS INFECTIONS
Hematogenous complications/bacteremia
o Occasionally polymicrobial
o Endocarditis (secondary to anaerobic
infection) or other distant infections
PLEUROPULMONARY INFECTION
Result from the aspiration of the oropharyngeal
contents
o Altered state of consciousness or
o Absent gag reflex
Four clinical syndromes are associated with
anaerobic pleuropulmonary infection produced by
aspiration:
1. Simple aspiration pneumonia -- simple infiltrate
by CXR
2. Necrotizing pneumonia - cavity formation in
CXR
3. *Lung abscess - accumulation of pus within the
lung parenchyma
4. *Empyema - accumulation of pus within the
pleural cavity, outside the lungs
*different treatment
o Lung abscess does not require surgery
(may cause Atelectasis, instead give
antibiotics for 4-6 weeks)
o Empyema requires surgical drainage
INTRAABDOMINAL INFECTIONS
Mainly peritonitis and abscesses - polymicrobial and
represent the normal intestinal (esp colonic) flora
Breach in the mucosal barrier resulting from
appendicitis, diverticulitis, neoplasm, inflammatory
bowel disease, surgery, or trauma
Predominance of enteric aerobic/facultative gramnegative bacilli, anaerobes and
streptococci/enterococci
PELVIC INFECTIONS
The vagina of a healthy woman is major reservoir of
anaerobic and aerobic bacteria
o Anaerobes outnumber aerobes by a ratio
of 10:1
o Anaerobic gram-positive cocci and
Bacteroides species
o Anaerobes are isolated from most women
with genital tract infections that are not
caused by a sexually transmitted pathogen
o
o
Necrotizing fasciitis
o Rapidly spreading destructive disease of the
fascia usually attributed to a group A
streptococci
o Mixed infection involving anaerobes and
aerobes, usually after surgeries and in
patients with diabetes or peripheral
vascular disease
o Most frequently isolated anaerobes in these
infections are Peptostreptococcus and
Bacteroides species
o Gas may be found in the tissues
o Deeper into the fascia
o Do fasciotomy to release pressure
o Compartment syndrome may be a
complication
Fournier's gangrene
o Cellulitis involving the scrotum, perineum
and anterior abdominal wall
o Mixed anaerobic organism spreading along
deep external fascial planes and causing
extensive loss of skin
Bacteroides, peptostreptococcus,
clostridium enterococcus and proteus sp
Associated with a higher frequency of
fever, foul-smelling lesions, gas in the
tissues and visible foot ulcer, necrotizing
fasciitis
DIAGNOSIS
There are three critical steps in the diagnosis of
anaerobic infection:
1. Proper specimen collection
ANTIBIOTIC THERAPY:
In many infections, anaerobes are mixed with
coliforms and other facultative organism
The best therapeutic regimens - active against both
aerobic and anaerobic bacteria
1. Metronidazole
o Needs to be given in combination with
aerobic bacterial coverage because it does
not have coverage for gram (+) aerobes
o Below the diaphragm, aerobic gram
negative coverage is needed; add
cephalosporin 3rd or 4th gen
o For infections from an oral source, aerobic
gram positive coverage; add first or second
gen cephalosporins or amoxicillin
2. Carbapenems (imipenem, meropenem,
doripenem)
o Good coverage for aerobic gram (+) and ()
organism and anaerobes
6. Penicillin
o At high doses= gram + anaerobe (e.g.
Peptostreptococcus)
o For streptococcus species
o Given for oropharyngeal infections
o If at very high doses, may have anaerobic
activity
7. Cephalosporins
o 1st and 2nd gen - good coverage for gram +
o 3rd and 4th - gram negative aerobic
o needs to be combined with metro or clinda
8. Vancomycin
o MRSA organisms
o Gram + aerobic
o Has some anaerobic coverage
o If very sever anaerobic, vanco + metro
9. Tigecycline
o New drug
o Has good coverage for MRSA, for gram ()
intraabdominal infections / organism
o Given with metronidazole
o No anaerobic coverage
MEDICINE 2:
PNEUMOCOCCAL INFECTIONS
Epidemiology:
- Pneumococcal infections significant
global cause of morbidity and death (even
with the advent of antibiotics)
o Particularly among children and
elderly
- Pneumoccoci are divided into serogroups
or serotypes based on the capsular
polysaccharide
structure
(Quellung
reaction)
- Not all pneumococcal serotypes are
equally likely to cause disease
o Some causes mild diseases, and
o
Strep.
Pneumoniae/Pneumococci
transmission
infection later
or
destruction
of
encapsulated
organism
If
no
spleen,
all
encapsulated organisms will
not be cleared by the body
Give vaccinations against strep
pneu, strep meningitidis, HIB
Chronic respiratory disease COPD,
bronchial asthma, cystic fibrosis
Chronic kidney disease
o For
patients
undergoing
hemodialysis
Chronic liver disease
DM
Immunocompromised/immunosuppresionHIV/AIDS,
chemotherapy,
pts
with
malignancy, pts receiving high dose
steroids
Cochlear implants
CSF leaks
o
MISCELLANEOUS
- Infancy and old age
- Prior hospitalization
- Alcoholism
- Cigarette smoking
- Day-care center attendance
- Residence in military training camps
- Prisons
- Homeless shelters
PATHOGENESIS
- From nasopharynx, bacterial spread via:
o Blood stream to distant sites
Brain,
joint,
bones,
peritoneal cavity (sterile
sites)
o Spread locally to mucosal surfaces
causing
otitis
media
or
pneumonia
-
MEDICINE 2:
Eventually
results
in
the
development of capsule-specific
serum IgG
Play a role in mediating
clearance of bacteria from
the nasopharynx
PNEUMONIA
- Most common
syndrome
serious
PE
-
presumptive
pneumococcal
Presenting manifestations:
- Abrupt onset of cough and dyspnea, fever
and chills, myalgia
Complications:
Empyema
o MC complication
o Collection of pus outside the lungs,
within pleural cavity
MEDICINE 2:
o
o
PNEUMOCOCCAL MENINGITIS
- Presents as a pyogenic condition
- Primary or a complication of other
conditions
o Skull fracture
o Otitis media
o Bacteremia
o Mastoiditis
- Routine Hib vaccine S. pneumoniae and
N. meningitides MC causes of bacterial
meningitis in adults and children ***
Clinical Manifestations:
- Non specific
- Severe,
generalized,
gradual
onset
headache, fever, nausea
- CNS manifestations
o stiff neck, photophobia, seizures,
confusion
- Clinical signs toxic appearance, altered
consciousness, sometimes bradycardia
and hypertension
- Kernigs or Brudzinkis sign or cranial
nerve palsies (3rd and 6th CN)
Definitive diagnosis:
Examination of CSF(Lumbar Tap):
- Evidence of turbidity (visual inspection)
- Elevated CHON level, elevated WBC,
reduced
glucose
concentration
***
(quantitative measurement) bacterial
meningitis
- Specific identification of etiologic agent
(Gram Stain, culture, antigen testing or
PCR)
- Blood culture for S. pneumoniae with
clinical manifestations of meningitis -->
confirmatory
Mortality rate approximately 20%
Acute and chronic complications
o Diffuse brain swelling,
o Subarachnoid hemorrhage,
o
o
o
Hydrocephalus,
Cerebrovascular
complications(arteritis or infarcts),
Hearing loss
Otitis media
Treatment:
Penicillin G
Ampicillin,
cefotaxime,
ceftriaxone and cefuroxime
Macrolides
(azithromycin,
clarithromycin)
and
cephalosporins
Clindamycin,
tetracycline,
TMP-SMZ
Penicillin-resistant
pneumococci
- Drug of choice
susceptible organisms
for
Meningitis
- Higher dose and longer duration
- First line therapy:
o Vancomycin
+ cefotaxime or
ceftriaxone
Vancomycin + rifampicin
(allergy
to
beta-lactam
agents)
- Glucocorticoids(usually Dexamethasone)
significantly reduce rates of mortality,
severe hearing loss and neurologic
sequelae in adults
- Empiric treatment because result of
MEDICINE 2:
Start
with
vancomycin
cefotaxime or ceftriaxone
Prevention
Vaccination vs S. pneumoniae and
influenza viruses ( flu vaccines should
also be given because viral infections are
usually risk factors for the development
of bacterial infections)
2 KINDS OF PNEUMONIA VACCINE:
Capsular
- Recommended for > 65 y/o
Polysaccharide
(elderly)
Vaccine (PPV23)
- In the Philippines, it is given
to those who are 50 y/o and
above
- 2-64 y/o with medical
conditions- asplenic, with
DM, CKD, COPD, Bronchial
asthma
*Give every 5 years
Polysaccharide
- For infants and young
protein
Conjugate
children
Vaccine (PCV)
- In the Philippines, it is
recommended to give at the
age of > 65 y/o
- Efficacy vs IPD (Invasive
Pneumococcal
Disease),
pneumonia, otitis media,
nasopharyngeal colonization
and all-causes of mortality
STAPHYLOCOCCAL INFECTIONS
STAPHYLOCOCCUS AUREUS
- Most virulent, major cause of morbidity &
mortality for all staphylococcal species
- Part of the normal flora
o Anterior nares most frequent site
of colonization
o Vagina,
axilla,
perineum
and
oropharynx
o Reservoir of future S. aureus
infections
- Can invade the bloodstream/ cross the
mucosal barrier
atopic
heart
toxin
Responsible
for
the
formation of Abscesses
Toxic shock syndrome
Food poisoning
Staphylococcal
scalded
skin syndrome (SSSS)
Serotypes ETA, ETB
Serine protease activity
triggers exfoliation
MEDICINE 2:
o
o
o
Septic
-
Folliculitissuperficial
infection with central area
of purulence, induration and
erythema
Furuncles
(boils)more
extensive than foliculitis,
true abscess
Carbuncles collection of
furuncles; most commonly
located in lower neck area,
coalescence
of
smaller
abscess seen deeper in
the skin and subcutaneous
tissue
Mastitis
Impetigo, cellulitis
Hidradenitis
suppurativa
recurrent
follicular
infections
(axilla)
Surgical wound infections
MUSCULOSKELETAL INFECTIONS
S. aureus MC cause of bone infections
Hematogenous
dissemination
or
contiguous spread from a soft tissue site
o Hematogenous osteomyelitis in
children long bones
Adults MC location is vertebra causing
vertebral osteomyelitis, can be secondary
to:
o Endocarditis
(drug
users)
,
undergoing hemodialysis, diabetic
injection drug users
Epidural abscesses
arthritis
Trauma, surgery or hematogenous
Knees, shoulders, hips, phalanges
Joints
previously
damaged
osteoarthritis, Rheumatoid Arthritis
by
Pyomyositis
- Unusual infection of skeletal muscles in
tropical climates
- Usually with history of trauma
Abscess cytotoxin
TOXIN-MEDIATED DISEASES:
Toxic Shock Syndrome
- TSST-1 (endotoxin): seen in > 90% in
menstruating women
- Enterotoxins: high in non-menstruating
women
- Begins with a relatively non-specific flulike symptoms
o Menstrual cases 2-3 days after
the onset of menses
Case definition: mostly systemic:
- Fever: > 38.9 C
- Hypotension
- Diffuse macular rash with desquamation in
1-2 wks after onset
- Multisystemic involvement
o Hepatic
o Hematologic
o Renal
o Mucous membranes
o Gastrointestinal
o Muscular
o CNS
- Negative serologic/other test for measles,
lepto, RMSF
MEDICINE 2:
(MRSA)
Food Poisoning
- Secondary to inoculation of toxinproducing S. aureus into food by colonized
food handlers
- Custards, potato salad, processed meats
- Onset of diarrhea 1-6 hrs after ingestion
- n/v, diarrhea, hypotension, dehydration
- symptoms resolve within 8-10 hrs
- self- limiting; just hydrate
Staphylococcal Scalded Skin Syndrome (SSSS)
- most often in newborn and children
o localized
blister
formation
to
exfoliation of much of the skin
surface
o skin- fragile, tender, with thinwalled, fluid-filled bullae/ vesicle
o Nikolskys sign gentle pressure
results in rupture of lesions
denuded underlying skin
o mucous
membranes:
usually
spared
vs Steven Johnsons (skin
lesion,
bullae
formation
involving
the
mucous
membrane)
o fever, irritability with poor feeding
- Pictures: bullae and denuded skin; infant
erythematous with blister like formation
that has already ruptured
COAGULASE
NEGATIVE
STAPHYLOCOCCAL
INFECTIONS
- Less virulent than S. aureus
- MC causes of prosthetic-device infections*
o S.
epidermidis
elaborate
extracellular polysaccharide (slime)
Facilitates formation of a
protective biofilm on the
device surface
General principles of therapy:
- Selection of appropriate antimicrobial
therapy
- Surgical incision and drainage for all
suppurative collections
- Removal of prosthetic devices
- TSS and food poisoning supportive
therapy
Antimicrobial Therapy:
Sensitive to penicillin
Sensitive to methicillin
Resistant
to
Methicillin
Penicillin
Alt:
nafcillin,
oxacillin,
cefazolin
Nafcillin or oxacillin
Alt: cefazolin, vancomycin
Vancomycin
Prevention
- Hospital
setting:
handwashing
and
appropriate isolation procedures
- Topical antimicrobial agents (mupirocin) -eliminate nasal colonization to prevent
subsequent infection
o Apply at anterior nares every night
for 10 days
o
For
patients
Hemodialysis
and
dialysis
undergoing
peritoneal
STREPTOCOCCAL INFECTIONS:
Streptococci
Group A Strep (S.
pyogenes)
Group B Strep (S.
agalactiae)
Enterococci
Viridans
MEDICINE 2:
Complications:
- Peritonsillar or retropharyngeal abscesses,
sinusitis,
otitis
media,
meningitis,
bacteremia, endocarditis, pneumonia
- Most Frequent: Acute Rheumatic Fever,
Poststreptococcal Glomerulonephtiris
SCARLET FEVER
- Strep pharyngitis accompanied by a
characteristic rash
- Rash streptococcal pyrogenic exotoxin
A, B, C
o Begins on the 1st or 2nd day of
illness over the upper trunk,
extremities, spares palms and
soles
(vs foot and mouth dse
which involves the palms and
soles)
o Minute papules, sandpaper feel to
the skin
o Associated circumoral cyanosis,
strawberry tongue
o Subsides in 6-9 days, followed by
desquamation of the palms and
soles
- Become less common in recent years
- Picture
o Differentiate from rash of measles,
dengue fever, Chikungunya
SKIN AND SOFT TISSUE
IMPETIGO
- Superficial infection of the skin
- Caused primarily by group A streptococci
- Most often in young children conditions
of poor hygiene
- Usual site face (around nose and
mouth), and the legs
- Red papules, vesicular, pustular lesions;
coalesce to form characteristic honeycomb
crust
Treatment
- Penicillin
- Empiric regimen should cover for both
streptococci and S. aureus
o Dicloxacillin or cefalexin for 10
days
ERYSIPELAS
- Infections
involving
skin
subcutaneous tissue
- Portal of entry traumatic or
wound, insect bite or any break
integrity
o Bright red appearance
involved skin, plateau
and
surgical
in skin
of the
sharply
demarcated
from
surrounding
normal skin
o Warm to touch, tender, appears
shiny and swollen
o Peau
d
orange
texture
involvement
of
superficial
lymphatics
o Malar area of the face and lower
extremities
Treatment: Penicillin
Picture
necrotizing
fasciitis
or
myositis or gangrene
- Treatment
o Clindamycin more effective in
rapidly
terminating
toxin
production than penicillin
o Penicillin
o IV Ig- adjunctive therapy for
streptococcal TSS
DIPHTHERIA
Corynebacterium diphtheriae
- Aerobic,
nonmotile,
nonsporulating,
irregularly staining, gram-positive rod
- Club-shaped,
arranged
in
clusters
(Chinese letters) or parallel arrays
- Both tox + and tox strain are infectious
MEDICINE 2:
Respiratory Diphtheria
- Case definition used by CDC
o Clinical syndrome URTI with sore
throat, low-grade fever and an
adherent membrane of the tonsils,
pharynx and/or nose
o Laboratory criteria isolation of C.
diphtheria from a clinical specimen
or histopathologic diagnosis of
diphtheria
- Complications:
o Obstruction of the respiratory tract
o Myocarditis and polyneuropathy
toxic manifestations of diphtheria
Picture: membrane over the tonsillar area
Treatment
- Diphtheria antitoxin most important
element in the treatment
- Antibiotics little demonstrated effect on
the healing in patient treated with
antitoxin
- Primary goal of antibiotic therapy
eradication and prevention of transmission
from the patient to susceptible contacts
o Erythromycin PO or Pen G IM x 14
days
Prevention
- DTaP children up to 7 y/o
- Td (Tetanus and diphtheria) adult use,
booster immunizaition at 10 years interval
o 0,1,6 tetanus toxoid
- Close contact, household contacts 7-10
days prophylaxis with erythromycin or
penicillin
----end.
MEDICINE 2:
LISTERIA MONOCYTOGENES
Food borne pathogen- serious infection in
pregnant women and
immunocompromised individuals
Infection follows ingestion of
contaminated food- the person should
ingest large or high concentration of the
organism to produce the disease
Entry into cells: mediated by host surface
proteins (internalin)
Internalin-mediated entry and is
important in crossing intestinal, bloodbrain and mucoplacental barrier
Listeriolysin O (LLO)- one of the
determinants which mediates the rupture
of phagosomal membrane following
phagocytosis of the organism
3.
Meningitis
5-10% of all cases of community acquired bacterial
meningitis in adults
Diagnosis is considered in all older and chronically ill
adults
Subacute illness, nuchal rigidity and meningeal signs
less common hence the diagnosis might be missed
o The Subacute course of the illness
differentiates it with meningitis caused by
other etiologic agent
CSF: WBC 100-500/uL, neutrophilic predominance,
low glucose
o WBC count is higher than bacterial yield,
protein is normal
Usually associated with hydrocephalus
4.
5.
Groups at risk
Pregnant women, elderly, neonates,
immunocompromised by organ transplants (due to
immunosuppresants), cancer or treatment with TNF
antagonists or glucocorticoids
Chronic medical conditions: alcoholism, diabetes,
renal disease, rheumatologic illness, iron overload
Clinical syndromes
Gastroenteritis
Bacteremia
Meningitis
Meningoencephalitis and focal CNS infection
Infection in pregnant women and neonates
1.
Gastroenteritis
Develops within 48hrs after ingestion of a loarge
inoculums of bacteria in contaminated foods (milk,
delimeates, salads, soft cheeses, hotdogs)
Fever, diarrhea, headache and constitutional
symptoms
Outbreaks
Diagnosis blood culture or stool culture
2.
Bacteremia
Fever, chills, myalgias/arthralgias
o Fever and chills are the usual symptoms
Meningeal symptoms, focal neurologic findings,
mental status changes
Organism is documented in 70-90% of cancer
patients with listeriosis
o We can easily grow this organism
MEDICINE 2:
Treatment
Ampicillin- drug of choice (high dose)
Penicillin also highly effective
Gentamicin + ampicillin - synergistic activity
TMP-SMX alternative for penicillin allergic patients
Cephalosporins are not effective
Neonates: ampicillin + gentamicin- synergistic
activity
Duration of treatment
o Bacteremia-2wks
o Meningitis-3wks
o Endocarditis-4-6wks
o Brain abscess/encephalitis-6-8wks
o Patient must complete the course; if not
completed relapse may occur and is harder
to treatment
TETANUS
2 exotoxins: tetanospasmin (causes the pathology of
spasms) and tetanolysin
Contamination of wound with spores
o Germination and toxin production in
devitalized tissues, foreign bodies, active
infecton
o Toxin binds to peripheral motor neuron
terminalsaxonsnerve cell body in the
brainstem and spinal cord by retrograde
intraneural transport
o Presynaptic terminals- blocks the release of
glycine and GABadinminishes inhibition
rigidity
o Consequent producton of spasms,
increased avtivity of reflexes that limit
spread of impulses
Types
1. Generalized tetanus
Most common form
Increased muscle tone and generalized spasm
Trismus or lockjaw
Dysphagia, stiffness or pain in the neck, shoulder and
back muscles
Rigid abdomen and stiff proximal limb muscles
Risus sardonicus- sustained contraction of facial
muscles
Opisthotonus- contraction of the back muscles
Autonomic dysfucction e.g. hypertensive then
sudden hypotension or tachycardia then sudden
bradycardia, excessive sweating
Neonatal tetanus is under general tetanus
2. Local/cephalic tetanus
Diagnosis
Based entirely on clinical findings- need a very high
suspicion for diagnosis
Wounds should be cultured in suspected cases
Treatment
Goals of therapy
o Eliminate the source of the toxin
o Neutralize unbound toxin
o Prevent muscle spasm
o Provide respiratory support
Spasm of back and abdominal
muscles impair respiratory function
Most common cause of death is
respiratory failure
Antibiotic therapy
o Eradicate vegetative cells penicillin
o Metronidazole- drug of choice, preferred
due to the absence of activity antagonistic
to GABA
o Penicillin
o Clindamycin and erythromycin
st
1 thing given is the antitoxin or tetanus
immunoglobulin
o Neutralize circulating toxin and unbound
toxin in the wound
o TIg STAT- may save the patient
o Should be given immediately and within 24
hours it effectively lowers mortality
Control of muscle spasm
o Sedatives
o Diazepam, lorazepam, midazolam
o Barbiturates and chlorpromazine
Respiratory care
o Immediate intubation or tracheostomy with
or without mechanical ventilation
o Give mechanical ventilation if respiration is
impaired
Autonomic dysfunction
o Hypertension and tachycardia or
Sympathetic over reactivity
Labetolol, esmolol, clonidin and
morphine sulfate
o Hypotension and bradycardia
Volume expansion, use of
vasopressors or chronotropic
agents or pacemaker insertion
Vaccine
o Active immunization during recoveryImmunity is not induced by a small amount
of toxin that produces the disease
o Give vaccine during recovery and not on the
active phase of the infection
o If you had tetanus infection in the past it
does not mean you will never have it again
MEDICINE 2:
Prevention
o
Active immunization-Td
All partially immunized and
unimmunized adults should
receive vaccine
Primary series for adults should
receive vaccine
Primary series for adults- 3 doses
(0,1,6-12 mos after 2nd dose)
Booster dose is required every 10years
If a patient is not sure of his
tetanus vaccination, is it ok to
give? YES
Vaccine given during the 1st year of
life- booster dose at ten years old
then another booster at 20 years
old
Proper wound management
BOTULISM
Paralytic disease potent protein neurotoxin
elaborated by C. botulinum
Case classification
o Food borne botulism- from canned goods
that are expired
o Wound botulism
o Intestinal botulism- causes diarrhea
currently less cases of botulism are noted s
Bioterrorism and biological warfare
o Dispersed as an aerosol (inhalational
botulism)
o Contaminant in material to be ingested
(food-borne)
Diagnosis
o Clinically, symmetrical descending paralysis,
afebrile, mentality intact
Differentiate it with CVD or stroke
o Demonstration of toxin in serum by
bioassay-definitive dianosis
o
o
MEDICINE 2:
Pathogenesis
Spores of toxigenic difficile are ingested- survive
gastric acidity that is why these organisms can go to
the colon
Germinate in the small bowel
Colonize the colon and elaborate 2 toxins
o Toxina a (enterotoxin) and toxin b
(cytotoxin)
o Initiate processes resulting in the disruption
of epithelial cell barrier function, diarrhea
and pseudomembrane formation
Clinical manifestations
Diarrhea- most common manifestation
o Stools almost never grossly bloody, soft to
uniformed, watery to mucoid in consistency
o +/- 20 bowel movements per day high
bowel output
Fever, abdominal pain and leukocytosis
Adynamic ileus results in cessation of stool passage
o Complications: toxic megacolon and sepsis
o Need a high index of suspicion to diagnose
o Eg. Initially a patient had diarrhea for 3 days
but stops on the 4th day due to the
development of adynamic ileusif the
physician does not recognize this it will
progress to sepsis
Treatment
Initially stop the antibiotics
Initial episode
o Mild to moderate- oral metronidazole
o Severe- oral vancomycin
Initial episode, severe, complicated or fulminant
o Vancomycin +metronidazole
o Rectal instillation of vancomycin
st
1 recurrence- same management as initial episode
nd
2 recurrence- vancomycin in tapered/ pulse
regimen
Multiple recurrences
o Repeat vancmoycin taper/pulse
o Vancomycin +saccharomyces bouldardii
o Rifaximin
o Nitazoxanide- not available in the phls
o Fecal transplantation
Rationale: bring back the normal
flora
It can be that feces will be infused
but where will they get the feces?
o IV Immunoglobulin
MEDICINE 2:
Lipooligosaccharides
Potent endotoxic activity
Mediates the induction of
inflammatory cytokines
Meningococcemia
- Fever, chills, nausea, vomiting, myalgia
- Prostration is common
- Most distinctive feature is rash
o Erythematous macules petechial
purpuric
o Petechiae may coalesce into hemorrhagic
bullae necrosis ulceration
Vs dengue: bigger petechiae than
petechiae in dengue, violaceous
rather than reddish
Concomitant meningitis
10-30% of meningococcemia without clinically
apparent meningitis
MEDICINE 2:
Chronic meningococcemia
o Rare syndrome of episodic fever, rash,
arthralgia weeks to months
o Maculopapular to petechial rash,
splenomegaly
o Be cautious with giving steroids may
cause meningitis, fulminant
meningococcemia
Waterhouse-Friedrichsen Syndrome
o DIC-induced microthrombosis, hemorrhage
and tissue injury
o Adrenal failure, adrenal hemorrhage
Diagnosis
- Most useful clinical finding petechial, purpuric
rashes
- Definitive diagnosis
o Isolation of bacteria from sterile sites
blood, CSF or synovial fluids
o Mueller-Hinton or chocolate blood agar
Clinical Management in the Hospital Setting
- The clinical management of meningococcal disease
consists of the following
o Diagnostic work up
o Use of antibiotics
o Supportive therapy
o chemoprophylaxis
-
Use of antibiotics
Antibiotic
Benzyl penicillin
Ceftriaxone
Cefotaxime
Chloramphenicol
Treatment
Child 250, 000 u/kg/day,
(Maximum 12 million u/day)
Adult: 1.8 g IV every 4 hours
To be given in 4 divided doses
for 7-10 days
Child: 75-100 mg/kg/day
(maximum 4 gm/day)
Adult: 2 or 4 gm IV
To be given in 1 or 2 doses for
7-10 days
Child: 200 mg/kg/day
(maximum 8 gm/day)
Adult: 2 g IV
To be given IV every 6 hours
for 7 days
Child: 75-100 mg/kg/day
(maximum 2 gm/day)
Supportive therapy
o Oxygen, intubation (ARDS)
o IV fluids
D5LRS, D5 0.90 NaCl or plain LRS
Colloids
o Use of steroids remain controversial
Chemoprophylaxis
o Household contact of an index case
o Young daycare center contacts
o Persons who have had significant contact
with the oral/nasal secretion of an index
case
o Health care workers who have had intimate
exposure to nasopharyngeal secretions (e.g.
mouth to mouth resuscitation, intubation)
Dose
Duration
Cautions
5mg/kg
orally every
12 hour
2 days
<1mo
10mg/kg
(minimum
600mg)
orally every
12 hour
2 days
May interfere
with efficacy of
oral
contraceptives
and some seizure
prevention and
anticoagulant
medications;
may stain soft
contact lenses
Ceftriaxone
15y
125mg IM
SD
>15y
250mg IM
SD
500mg
orally
SD
Ciprofloxacin
18y
To decrease pain
at injection site,
dilutewith 1%
lidocaine
Not
recommended
for people <18
y/o
Prevention
- Meningococcal vaccine
o Available as bivalent (groups A and C) or
tetravalent (groups A,C,Y,W135) vaccines
- Isolation precautions
o Respiratory isolation for the first 24 hours
Transmission is via respiratory
route
MEDICINE 2:
Outbreak control
o Occurrence of 3 or more cases within <3
months in persons who reside in the same
area
o Mass vaccination
o Mass chemoprophylaxis
B. NEISSERIA GONORRHEA
Gonorrhea
- Remains a global public health problem worldwide
- Plays a role in enhancing transmission of HIV
- Transmitted from males to females more efficiently
- Rate of transmission to a woman following a single
unprotected sexual encounter with an infected man
-40-60%
Gonococcal Arthritis
- Disseminated Gonococcal infection (DGI)
o Results from gonococcal bacteremia
o DGI strains resists bactericidal action of
human serum
Do not incite inflammation at the
genital sites
Po1A serotype
o Menstruation risk factor, 2/3 of cases are
women
-
Gonococcal vaginitis
o Occurs in anestrogenic women (prepubertal
girls and postmenopausal women)
o Vaginal mucosa red and edematous,
abundant purulent discharge
o Inflamed cervical erosions and abscesses
Clinical Manifestations
o Bacteremic stage
Fever and chills
Painful joints, tenosynovitis and
skin lesion (pustules and papules)
Polyarthralgias knees, elbows,
distal joints; axial skeleton spared
o Joint localized stage with suppurative
arthritis
Septic arthritis knees, wrists,
ankles and elbows
Laboratory Diagnosis
- Gram stain of urethral exudates
o Gram negative intracellular monococci or
diplococci - highly selective and sensitive
- Modified Thayer Martin Agar
- DGI - blood and synovial fluid culture
Recommended Treatment for Uncomplicated GC
- Cefixime 400mg PO single dose or Ceftriaxone
125mg SD + Azithromycin 1g PO SD or Doxycycline
100mg PO BID x 7 days
o Gonorrhea is almost always associated with
Chlamydia so give coverage for Chlamydia
Prevention
- A-B-C
o Abstinence
o Be faithful
o Condom
- Spermicidal preparation with diaphragm and cervical
sponges
- All sexual partners should be evaluated and treated
o ping pong effect
C. MORAXELLA CATARRHALIS
- Gram-negative cocci
- Sometimes occurring in pairs kidney bean
configutaion
- Normal flora of upper airways
- Otitis media and sinusitis
MEDICINE 2:
D. HAEMOPHILUS INFECTIONS
- Gram-negative organism of variable shape
o Pleomorphic coccobacillus
- 2 factors required for growth
o X (hemic) and V (NAD) factors
- 6 serotypes based on distinct polysaccharide capsule
(a-f)
- Type b and nontypable strains most relevant
strains clinically
- 1st free living organism to have its entire genome
sequenced
Transmission
- Airborne droplets or direct contact with secretions
or fomites
- Nontypable strains colonize the upper respiratory
tract of up to of healthy adults
o HiB conjugate vaccine decrease in
nasopharyngeal colonization and incidence
of infection
Pathogenesis
- Hib strains invasion and hematogenous spread to
distant sites such as the meninges, bones and joints
o Type b polysaccharide capsules
Important virulence factor
Avoids opsonisation and cause
systemic disease
*asplenic patients cannot clear
encapsulated organism (S. pneumoniae, N.
meningitides, Hib) should receive
vaccination for these organisms
-
Nontypable strains
o Local invasion of mucosal surfaces
o Otitis media, chronic bronchitis recurrent
lower respiratory tract infection
Diagnosis
- Recovery of the organism in culture
- Gram staining- gram negative coccobacilli
Treatment
- Meningitis
o Ceftriaxone or cefotaxime
o Ampicillin + Chloramphenicol
o Glucocorticoids decrease neurologic
sequelae
- Nontypable strains
o 25% produce B lactamase
Resistant to ampicillin
o TMP-SMX, amoxicillin/clavulanic acid,
extended spectrum cephalosporin, newer
macrolides, fluoroquinolones
Prevention
- Hib conjugate vaccine all children
E. HAEMOPHILUS DUCREYI
- Chancroid
o STD genital ulceration and inguinal
adenitis
MEDICINE 2:
o
o
Clinical Manifestation
o Break in the epithelium during sexual
contact with an infected individual
o Incubation period of 4-7 days
The initial lesion a papule with
surrounding erythema
o Papule evolves into a pustule - ruptures
and form a sharply circumscribed ulcer that
is generally not indurated
o Ulcers are painful and bleed easily
o Develop enlarged, tender inguinal lymph
nodes fluctuant and spontaneously
rupture
o Patients usually seek medical care after 1-3
weeks of painful symptoms
o Clinical picture can be confused with that of
lymphogranuloma venerum
o DDx: primary syphilis, conyloma latum of
secondary symphilis, genital herpes and
donovanosis
F. LEGIONELLA INFECTION
- Legionella pneumophila
o Aerobic gram-negative bacilli, do not grow
on routine microbiologic media
o 80-90% of human infections
o Direct fluorescent antibody (DFA) for
diagnosis
Diagnosis
o Clinical diagnosis often inaccurate
o Gram staining of a swab of the lesion may
reveal a predominance of characteristic
gram-negative coccobacilli
o An accurate diagnosis of chancroid relies on
culture of H. ducreyi from the lesion
o Aspiration of culture of suppurative lymph
nodes
Treatment
o Azithromycin 1g SD
o Alternative regimens include
Ceftriaxone 250mg IM SD
Ecology
Aquatic bodies, lakes and streams
Grow and proliferate in human
constructed aquatic reservoir
Factors known to enhance
colonization
Warm temp, stagnation,
scale and sediment
From microcolonies and biofilms
Transmission
Source - water
Aerosolization, aspiration and
direct instillation in to the lungs
during respiratory tract
manipulation
Aspiration predominant
mode of transmission
Aerosolization by devices
filled with tap water,
including nebulizers and
humidifiers
Legionnaires Disease
o atypical pneumonia
Diarrhea
High fever - >40C
Numerous neutrophils but no
organisms revealed by GS of
respiratory secretions
Hyponatremia
Failure to respond to B-lactams
and aminoglycoside antibiotics
Occurrence of illness in an
environment where water is
contaminated with Legionella
Onset of symptoms 10 days after
discharge from hospital
o
Treatment
Macrolides
MEDICINE 2:
Azithromycin
Clarithromycin
Quinolones
Tetracycline
TMP-SMX
Paroxysmal phase
o Cough becomes more frequent and
spasmodic
o Repetitive bursts of 5-10 coughs within a
single expiration, audible whoop
o Lasts 2-4 weeks
Convalescent phase
o Last from 1-3 months
o Gradual resolution of coughing episodes
o Intercurrent viral infections associated
with recrudescence of paroxysmal cough
Complications
- Subconjunctival haemorrhages, abdominal and
inguinal hernias, pneumothorax, facial and truncal
petechiae
o Increase intrathoracic pressure severe fits
of coughing
Diagnosis
- Classic symptoms of pertussis
Laboratory confirmation
o Lymphocytosis common among young
children
o Gold standard culture of nasopharyngeal
secretions/aspiration
Media: Bordet-Gengou or ReganLowe
Treatment
- Antibiotics
o Eradicate infecting bacteria from the
nasopharynx
Does not alter clinical course
unless given early in the catarrhal
phase
o DOC: Macrolides
TMP-SMX
- Chemoprophylaxis household contacts
o Erythromycin
- Immunization
o Mainstay of pertussis infection
o Lifelong immunity after natural infection
MEDICINE 2:
B.KLEBSIELLA INFECTION
Extraintestinal Pathogenic Strains (EXPEC)
- Infections in the urinary tract, bloodstream, CSF,
respiratory tract, peritoneum
- Surgical and wound infections, osteomyelitis and
myositis
Urinary Tract Infection
- Most frequent site infected by EXPEC
- E. coli single most prevalent pathogen for all UTI
- Most common source of E. coli bacteremia
- Uncomplicated cystitis/urethritis most common
o Dysuria, frequency and suprapubicpain
- Pyelonephritis
o Fever, costovertebral tenderness, nausea
and vomiting
- Abdominal and pelvic infections
o Second most frequent site of extraintestinal
infection due to E.coli
o Acute peritonitis secondary to fecal
contamination, spontaneous bacterial
peritonitis, diverticulitis, appendicitis,
intraperitoneal abscesses, cholangitis
Pneumonia
- E. coli is not a usual pathogen
- Long term care facilities
o GNB common cause of pneumonia
60-70% of hospital acquired
pneumonia
Meningitis
- E. coli one of the 2 leading cause of neonatal
meningitis
o Group B streptococcus
- Strains posses K1 capsular serotype
- Uncommon in older children and adults
o Disruption of meninges due to craniotomy
or trauma, in the presence of cirrhosis
Treatment
- Highly susceptible to antibiotics
- Increasing frequency of ampicillin resistance
o Precludes its empiric use in community
acquired infections
st
- Increasing rates of resistance to 1 generation
cephalosporinsand TMP-SMX
- TMP-SMX DOC for uncomplicated cystitis
- Resistance to B-lactam/BLI: 30-40%
- Rates of resistance to cephalosporins (2nd, 3rd, 4th
gen), quinolones, monobactam, quinolone and
aminoglycosides: <10%
- Acquisition of plasmid containing ESBLs (extendedspectrum beta lactamases)
o DOC: Carbapenem
MEDICINE 2:
UTI
-
Ozena
- K. ozenae
- Primary atrophic rhinitis that often occurs in elderly
persons
- Common symptoms
o Nasal congestion and a constant nasal bad
smell
o Headache
Treatment
- Severely ill patients
o Third-generation cephalosporins,
carbapenems, aminoglycosides and
quinolones
o Intrinsically resistant to ampicillin and
ticarcillin
- Extended Spectrum Beta Lactamases (ESBL)producing strains DOC: carbapenems
C. PROTEUS INFECTION
- Proteus organisms are implicated as serious causes
of infections in humans
- Normal human intestinal flora
- Multiple environmental habitat, including long term
care facilities and hospitals
o Colonize both the skin and oral mucosa of
both patients and hospital personnel
Proteus mirabilis
- 90% of proteus infections
- Community acquired infection
- Urease production + presence of bacterial motility
and fimrbiae favors the production of upper
urinary tract infections
Risk factors
- Recurrent infections
- Structural abnormalities of the urinary tract
- Urethral instrumentation
Pathophysiology
- Proteus organisms produce urease and able to
alkalinize the urine by hydrolyzing urea to ammonia
o Leads to precipitation of organic and
inorganic compounds struvite stone
formation
Composed of a combination of
magnesium ammonium
phosphate(struvite) and calcium
carbonate - apatite
Other infections
- Pneumonia
- Nosocomial sinusitis
- Intraabdominal abscesses
- Biliary tract infection
- Surgical site infection
- Soft tissue infection (decubitus and diabetic ulcers)
- Osteomyelitis (primarily contiguous)
Treatment
- Uncomplicated UTIs in women
o Oral quinolone for 3 days or
trimethoprim/sulfamethoxazole (TMP/SMZ)
for 3 days (OPD basis)
-
D. ENTEROBACTER INFECTIONS
- Enterobacter cloacae and E. aerogenes
o Important community-acquired and
nosocomial pathogens
MEDICINE 2:
Community-acquired infections
o UTIs, skin and soft tissue infections, and
wound infections
Treatment
o Significant antimicrobial resistance exists
o Ampicillin and 1st and 2nd gen
cephalosporins have little or no activity
rd th
o Extensive use of 3 -4 gen cephalosporins,
monobactams, B-lactam/B-lactamase
inhibitor
Production of high levels of betalactamases
o Imipenem, cefepime, , aminoglycosides,
TMP-SMX, Fluoroquinolones
Retained excellent activity (9099%)
E. ACINETOBACTER INFECTIONS
- A. baumannii
- Highly prevalent in the environment
- Increased colonization of the skin, respiratory and
GIT
o Individuals in long-term care facilities and
hospitals
Infectious syndromes
- Respiratory tract (ventilated patients)
- Intravascular devices
- Severe CAP uncommon
o Affects compromised hosts alcoholics
- Infections of catheterized urinary tract, post-op sites,
burn sites, biliary stents and sinuses
Treatment
- Many strains highly resistant to antimicrobial
agents
- Empiric combination
- Ampicillin, aztreonam, 1st-2nd gen cephalosporin
little or no activity
- Resistance rates: 20-50%
o Piperacillin, quinolones, 3rd gen
cephalosporin, gentamicin
- Imipenem most active agent (>95%)
- BL/BLI, cefepime, amikacin
F. SERRATIA INFECTIONS
- S. marcescens - >90% of infections
- Primarily seen in the environment - moist foci
- Healthy humans rarely colonized
- Reservoirs 0 HCW, food, milk in neonatal units, sink,
respiratory and other hospital equipment
Infectious syndromes
- Respiratory, genitourinary tracts, intravascular
devices , surgical wounds
- Soft tissue infections (myositis, osteomyelitis),
abdominal and biliary tract
infections(postprocedural), contact lens associated
keratitis, endophthalmitis, septic arthritis, infusion
related bacteremias less common
Treatment
st
- >80% of strains resistant to ampicillin and 1 gen
cephalosporins
- >90% of isolates are susceptible to other GNBappropriate antibiotics
G. CITROBACTER INFECTIONS
- C. freundii and C. koseri majority of human
infections
- Epidemiologically and clinically similar to
Enterobacter and Acinetobacter infections
- Present in water, food, soil and intestinal tract of
animals
- Colonization increasing in long term care facilities
and hospitals
- Citrobacter species account for 1-2% of nosocomial
infections
Infectious Syndromes
- Urinary tract most common site of infection (4050%)
- Less commonly infected sites
o Biliary tree, respiratory tract, surgical site,
soft tissue, peritoneum, intravascular
devices
- Uncommon cause of neonatal meningitis
o C. koseri 90% of cases
Complication brain abscess (5080%)
Treatment
- C. freundii is more resistant to antibiotics than C.
koseri
st
- Poor activity of ampicillin and 1 gen cephalosporin
- >90% of isolates are susceptible to other Gram
negative Bacteria -appropriate antibiotics
H. PSEUDOMONAS INFECTIONS
aerobic, gram negative bacterium of relatively low
virulence
- Ubiquitous with a predilection to moist
environments, primarily as waterborne and
soilborne organisms
- Pseudomonas aeruginosa colonization
>50% of humans
MEDICINE 2:
Pseudomonas aeruginosa
Pseudomonal pneumonia
o associated with mortality that occurs 34 days after the first signs or
symptoms of
pulmonary or
extrapulmonary infections
Ventilator-associated pneumonia (VAP) caused by
P. aeruginosa is associated with higher mortality
rates as high as 60% than VAPs caused by other
infectious organisms
Clinical syndromes
AIDS-related infections
Bacteremia and sepsis
Febrile neutropenia*
bone and joint infection
o (e.g. osteochondritis, osteomyelitis,
pyarthrosis)
CNS infection
o ( e.g. brain abscess, meningitis)
Ear infections
o (e.g. otitis media, chronic suppurative otitis
media, otitis externa, malignant external
otitis or swimmers itch*)
Eye infections*
o (e.g. endophthalmitis, keratitis, opthalmia
neonatorum, blepharoconjunctivitis, scleral
abscess, orbital cellulitis)
GI infections
o (e.g. epidemic diarrhea, NEC, typhitis, rectal
abscess, shanghai fever)
Cardiovascular (CV) infections
o (e.g. endocarditis, pericarditis, cardiac
tamponade)
Respiratory infections esp VAP*
o (e.g. primary or nonbacteremic, bactermic,
colonization, and nosocomial pneumonia,
lower respiratory tract infections of CF,
VAP)
Skin and soft tissue infections
o (e.g. burn wound sepsis, dermatitis,
Ecthyma Gangrenosum, pyoderma, surgical
and wound infections, including cellulitis,
hot tub folliculitis, necrotizing fasciitis,
chronic paronychia)
10
MEDICINE 2:
11
MEDICINE 2:
Pathogenesis
- Ingestion of organism via contaminated food and
water
organism invades the GIT tract
- Multiply in the mononuclear phagocytic cells in
Spleen, liver, and Peyers patches in terminal ileum
o Abdominal pain due to Infiltration in the
Peyers patches
Risk factors:
- Decrease stomach acidity
o Age <1 yr old, antacid ingestion, achlorydic
diseases
- Decrease intestinal integrity
o Problem in the GI mucosa
o IBD, prior GI surgery, anitiotic administration
(kill the normal flora)
Clinical Manifestations:
ENTERIC (TYPHOID) FEVER
- Incubation period: 10- 14 days (3 21 days)
- Most prominent symptom: prolonged fever (38.8 C
40.5 C), until for weeks if untreated
-
Diagnosis:
- Clinical presentation relatively non-specific
- Considered in any febrile traveler returning from a
developing country
- Gold standard culture positive for S. typhi or S.
paratyphoid
- Blood Culture and sensitivity 90% positive in the
first week of infection, 50% in the 3rd week
- BMA (bone marrow aspiration) remain highly
sensitive (90%) despite >5 days of Antibiotic
treatment
Treatment:
- Empiric treatment: (if still do not know if it is
salmonella or not)
o Ceftriaxone 1-2g/day (7-14 days)
o Azithromycin 1g/day (5 days)
- If fully susceptible
o Ciprofloxacin 500mg bid po, or 400mg every
12 h IV (5 7 days)
o Amoxicillin 1gram tid (14 days)
o Chloramphenicol 25mg/kg tid (14-21 days)
o TMP-SMZ 800mg
- Multi-drug resistant
o Ciprofloxacin 500mg bid po, or 400mg every
12h IV (5-7 days)
o Ceftriaxone 2-3g / day (7-14 days)
o Azithromycin 1g/day (5 days)
- Nalidixic acid resistant
o Same with multidrug resistant
Prevention
- Typhoid vaccines
o Ty 21 day, Oral live attenuated S. typhi
vaccine (given on days 1, 3, 5, 7 with booster
every 5 years)
o Vi CPS, purified Vi polysaccharide from
bacterial capsule (given in 1 dose with
booster of every 2 years)
NON-TYPHOIDAL SALMONELLOSIS (NTS)
- Serotypes: typhi murium, enteritidis
- Minor infections
- Highest rates of morbidity and mortality:
o Elderly
o Infants
o Immunocompromised
-
MEDICINE 2:
Clinical Manifestations:
- Gastroenteritis
o Nausea and vomiting, diarrhea occurs in 68 hours
- Bacteremia and endovascular infections
- Localized infections
o Hepatic splenic abscess, UTI, meningitis,
infectons in the bones
Diagnosis
- High index of suspicion - prolonged or recurrent
fever
- Isolation of organism
o Blood, stool, sterile body fluids
- Echocardiography
- CT scan/ MRI
o Intra-abdominal abscess, bone and joint
involvement
Treatment
- Increasingly prevalence of antibiotic resoistance
o Life threatening NTS bacteremia or focal NTS
infection
o 3rd gen. Cephalosporin, Fluoroquinolone
o Given 7 -14 days
- Patient with AIDS and NTS bacteremia
o 1-2 weeks of IV antibiotic followed by 4
weeks of oral therapy Fluoro
o Relapse give long term suppression therapy
of cotrimoxazole or fluoroquinolones
(indefinite time: 3-6 months)
SHIGELLA (SHIGELLOSIS)
Shugella dysenteriae, S. flexneri, S. boydii, S. sonnei
o MC species that cause human infection
Shigella dysenteriae type 1 etiologic agent of
dysentery
o Produces Shiga toxin (cytotoxin)
o Fecal oral route
o Some: water-borne transmission
Pathogenesis
- Resistance to low pH condition allows Shigella to
survive through the gastric barrier
- Small inoculum ( as few as 100 CFU) is sufficient to
cause infection
- Watery diarrhea that precedes the dysenteric
syndrome is attributable to active secretion and
abnormal water reabsorption
o Enterotoxin (SHET-1) and mucosal
inflammation
-
Clinical Manifestation
- Shigellosis typically evolves through 4 phases
o Incubation period (non specific), watery
diarrhea, dysentery,post infectious
a.
Incubation Period
o Last about 1-4 days, but maybe as long as 8
days
o Typically, initial manifestations are transient
fever, limited watery diarrhea, malaise and
anorexia
o S/Sx may change from mild abdominal
discomfort to severe cramp
o Tenesmus
b.
Toxic megacolon
is a consequence of severe
inflammation extending to the
colonic smooth muscle layer and
causing paralysis and dilatation
The patient present with abdominal
distention and tenderness with or
withput signs of localized or
generalized peritonitis
Predisposing factors:
Hypokalemia
Paralytic ileus
Opiods
Anti-cholinergic
Do not give anti diarrheal
meds
HUS
MEDICINE 2:
Lab. Dx
- Gold standard for diagnosis of shigella infection
remains the isolation and identification of the
pathogen from fecal material (stool Culture)
- Blood Culture positive in less than 5% of cases
(only done in severe sepsis)
Treatment
- First line
o Ciprofloxacin 500mg 1 cap bid x 3 days
- 2nd line
o Ceftriaxone
o Azithromycin
CAMPYLOBACTER INFECTIONS
Campylobacters are found in the GI tract of many
animals use for food
o Including poultry, cattle, shhep, and swine
o Also seen in household pets (dogs, cats)
Other mode of transmission
o Ingestion of raw (unpasteurized) milk or
untreated water
o Contact with infected household animals
o Travelling to developing countries
Clinical Manifestation
Campylobacter jejuni
- C. jejuni infections may be subclinical
o In host who have had multiple prior
infections and are partially immnune
- Symptomatic infections mostly occur within 2-4
days of exposure (range 1-7 days)
- Site of tissue injury: mostly in jejunum, but can have
infection in ileum and colon
- A prevalence of fever. Headache, myalgia and /or
malaise often occur 12 48 hours before the onset
of diarrheal symptom
Campylobacter enteritis
- Is generally self-limited
o But Symptoms may persist for > 1 week
Diagnosis
- Confirmation of diagnosis is based on the
identification of an isolate from culture of stool,
blood, or another site
- Campylobacter specific media should be used to
culture stool
Treatment
- Fluid and Electrolyte is central to the treatment of
diarrheal illness
- Even among patients presenting for medical
attention with campylobacter enteritis, not all will
clearly benefit from specific antibiotics
- Patients that will benefit from antibiotics:
(indications for antibiotics)
o High grade fever
o Bloody diarrhea
o Persistence for more than 1 week
o Worsening symptoms
-
CHOLERA INFECTIONS
Acute diarrheal disease that can result in profound,
rapidly progressing Dehydration and death
Cholera gravis severe form
o Caused by Vibrio cholera serogroup O1 or
O139
Toxin-mediated disease
o In small intestine: toxin-coregulated pilus its synthesis is regulated in parallel with that
of cholera toxin
MEDICINE 2:
Pathogenesis
- Cholera is a toxin mediated disease
- The watery diarrhea characteristic of cholera is due
to action of cholera toxin
o Potent protein enterotoxin elaborated by the
organism in the SI
o In small intestine: toxin-coregulated pilus its synthesis is regulated in parallel with that
of cholera toxin also enable the organism
to survive in the SI
Clinical Manifestations:
- Asymptomatic or have only mild diarrhea
- Sudden onset of explosive and life-threatening
diarrhea (cholera gravis)
- After a 24 48 hours incubation period begins with
sudden onset of painless watery diarrhea that may
quickly become voluminous
- Patient often vomits
- The stool has a characteristic appearance
o nonbilious, gray, slightly cloudy, fluid with
flecks of mucoid, no blood and somewhat
fishy, inoffensive odor
- Clinical symptoms parallel volume contraction:
o At losses of <5% of normal body weight,
thirst develops;
o at 510%, postural hypotension, weakness,
tachycardia, and decreased skin turgor are
documented; and
o at >10%, oliguria, weak or absent pulses,
sunken eyes (and, in infants, sunken
fontanelles), wrinkled ("washerwoman")
skin, somnolence, and coma are
characteristic.
- Complications derive exclusively from the effects of
volume and electrolyte depletion and include renal
failure due to acute tubular necrosis.
- if the patient is adequately treated with fluid and
electrolytes, complications are averted and the
process is self-limited, resolving in a few days.
Diagnosis
- The clinical suspicion of cholera can be confirmed by
the identification of V. cholerae in stool
- Laboratory isolation of the organism requires the use
of a selective medium such as taurocholate-telluritegelatin (TTG) agar or thiosulfatecitratebile salts
sucrose (TCBS) agar
- If a delay in sample processing is expected, CareyBlair transport medium and/or alkaline-peptone
water-enrichment medium may be used
- Standard microbiologic biochemical testing for
Enterobacteriaceae will suffice for identification of
V. cholerae. All vibrios are oxidase-positive.
Treatment
- Death from cholera is due to hypovolemic shock;
Antibiotics
- use of antibiotics diminishes the duration and
volume of fluid loss and hastens clearance of the
organism from the stool
- WHO recommends administration of antibiotics to
cholera patients only if they are severely
dehydrated,
- Doxycycline (a single dose of 300 mg) or
- tetracycline (12.5 mg/kg four times a day for 3 days)
may be effective in adults but is not recommended
for children <8 years of age because of possible
deposition in bone and developing teeth.
For nonpregnant adults with cholera in areas where
tetracycline resistance is prevalent
o ciprofloxacin [either in a single dose (30
mg/kg, not to exceed a total dose of 1 g) or
in a short course (15 mg/kg bid for 3 days,
not to exceed a total daily dose of 1 g)],
o erythromycin (4050 mg/kg daily in three
divided doses for 3 days),
o azithromycin (a single 1-g dose) may be a
clinically effective substitute.
- Pregnant women and children are usually treated
with erythromycin or azithromycin (10 mg/kg in
children).
MEDICINE 2:
Prevention
- Provision of safe water and facilities for sanitary
disposal of feces, improved nutrition, and attention
to food preparation and storage in the household
can significantly reduce the incidence of cholera
- Oral cholera vaccines
NON-CHOLERA VIBRIOSES
NONCHOLERA VIBRIOSES
ORGANISM
VEHICLE
OR
ACTIVITY
V.
Shellfish,
parahaemolyti seawater
cus
seawater
Non- O1/O139
V. cholerae
V. vulnificus
V. alginolyticus
HOST AT RISK
SYNDROME
Normal
Gastroenteri
tis
Normal
Wound
infection
Gastroenteri
tis
Wound
infection,
otitis media
Sepsis,
secondary
cellulitis
Wound
infection,
cellulitis
Wound
infection,
cellulitis,
otitis media
sepsis
Shellfish,
travel
Seawate
r
Normal
shellfish
immunosuppre
ssed
seawater
Normal,
immunosuppre
ssed
Normal
seawater
seawater
Normal
Burned, other
immunosuppre
ssed